Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 200

1.

Evaluating early preventive antipsychotic and antidepressant drug treatment in an infection-based neurodevelopmental mouse model of schizophrenia.

Meyer U, Spoerri E, Yee BK, Schwarz MJ, Feldon J.

Schizophr Bull. 2010 May;36(3):607-23. doi: 10.1093/schbul/sbn131. Epub 2008 Oct 8.

2.

Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia.

Meyer U, Feldon J, Schedlowski M, Yee BK.

Neurosci Biobehav Rev. 2005;29(6):913-47. Review.

PMID:
15964075
3.

Clozapine administration in adolescence prevents postpubertal emergence of brain structural pathology in an animal model of schizophrenia.

Piontkewitz Y, Assaf Y, Weiner I.

Biol Psychiatry. 2009 Dec 1;66(11):1038-46. doi: 10.1016/j.biopsych.2009.07.005. Epub 2009 Sep 2.

PMID:
19726031
4.

Tracing the development of psychosis and its prevention: what can be learned from animal models.

Piontkewitz Y, Arad M, Weiner I.

Neuropharmacology. 2012 Mar;62(3):1273-89. doi: 10.1016/j.neuropharm.2011.04.019. Epub 2011 Jun 23. Review.

PMID:
21703648
5.

Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia.

Ozawa K, Hashimoto K, Kishimoto T, Shimizu E, Ishikura H, Iyo M.

Biol Psychiatry. 2006 Mar 15;59(6):546-54. Epub 2005 Oct 26.

PMID:
16256957
6.

Maternal immune activation leads to age-related behavioral and immunological changes in male rat offspring - the effect of antipsychotic drugs.

Basta-Kaim A, Szczęsny E, Leśkiewicz M, Głombik K, Slusarczyk J, Budziszewska B, Regulska M, Kubera M, Nowak W, Wędzony K, Lasoń W.

Pharmacol Rep. 2012;64(6):1400-10.

7.

Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice.

Meyer U, Nyffeler M, Yee BK, Knuesel I, Feldon J.

Brain Behav Immun. 2008 May;22(4):469-86. Epub 2007 Nov 26.

PMID:
18023140
8.

Dysregulation of kisspeptin and neurogenesis at adolescence link inborn immune deficits to the late onset of abnormal sensorimotor gating in congenital psychological disorders.

Cardon M, Ron-Harel N, Cohen H, Lewitus GM, Schwartz M.

Mol Psychiatry. 2010 Apr;15(4):415-25. doi: 10.1038/mp.2009.66. Epub 2009 Jul 28.

PMID:
19636313
9.

Neural basis of psychosis-related behaviour in the infection model of schizophrenia.

Meyer U, Feldon J.

Behav Brain Res. 2009 Dec 7;204(2):322-34. doi: 10.1016/j.bbr.2008.12.022. Epub 2008 Dec 30.

PMID:
19154759
10.
11.

Decreased prepulse inhibition and increased sensitivity to muscarinic, but not dopaminergic drugs in M5 muscarinic acetylcholine receptor knockout mice.

Thomsen M, Wörtwein G, Fink-Jensen A, Woldbye DP, Wess J, Caine SB.

Psychopharmacology (Berl). 2007 May;192(1):97-110. Epub 2007 Feb 20.

PMID:
17310388
13.

Prenatal exposure to a repeated variable stress paradigm elicits behavioral and neuroendocrinological changes in the adult offspring: potential relevance to schizophrenia.

Koenig JI, Elmer GI, Shepard PD, Lee PR, Mayo C, Joy B, Hercher E, Brady DL.

Behav Brain Res. 2005 Jan 30;156(2):251-61.

PMID:
15582111
14.

Effects of clozapine on behavioral and metabolic traits relevant for schizophrenia in two mouse strains.

Zarate JM, Boksa P, Baptista T, Joober R.

Psychopharmacology (Berl). 2004 Jan;171(2):162-72. Epub 2003 Nov 13.

PMID:
14615871
15.

Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.

Gaisler-Salomon I, Weiner I.

Psychopharmacology (Berl). 2003 Apr;166(4):333-42. Epub 2003 Feb 22.

PMID:
12599023
16.

Acute or subchronic clozapine treatment does not ameliorate prepulse inhibition (PPI) deficits in CPB-K mice with low levels of hippocampal NMDA receptor density.

Wolf R, Paelchen K, Matzke K, Dobrowolny H, Bogerts B, Schwegler H.

Psychopharmacology (Berl). 2007 Sep;194(1):93-102. Epub 2007 May 31.

PMID:
17541558
17.

Neonatal polyI:C treatment in mice results in schizophrenia-like behavioral and neurochemical abnormalities in adulthood.

Ibi D, Nagai T, Kitahara Y, Mizoguchi H, Koike H, Shiraki A, Takuma K, Kamei H, Noda Y, Nitta A, Nabeshima T, Yoneda Y, Yamada K.

Neurosci Res. 2009 Jul;64(3):297-305. doi: 10.1016/j.neures.2009.03.015. Epub 2009 Apr 10.

PMID:
19447299
18.

A putative animal model of the "prodromal" state of schizophrenia.

Tenn CC, Fletcher PJ, Kapur S.

Biol Psychiatry. 2005 Mar 15;57(6):586-93.

PMID:
15780845
19.

Antipsychotic property of a muscarinic receptor agonist in animal models for schizophrenia.

Maehara S, Hikichi H, Satow A, Okuda S, Ohta H.

Pharmacol Biochem Behav. 2008 Nov;91(1):140-9. doi: 10.1016/j.pbb.2008.06.023. Epub 2008 Jul 2.

PMID:
18651995
20.

Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring.

Zuckerman L, Weiner I.

J Psychiatr Res. 2005 May;39(3):311-23.

PMID:
15725430

Supplemental Content

Support Center